Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Cognition Disorders (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cognition Disorders (diet therapy) < Cognition Disorders (drug therapy) < Cognition Disorders (economics)  Facettes :

List of bibliographic references indexed by Cognition Disorders (drug therapy)

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000250 (2015) Ji Hyun Ko [États-Unis] ; Renata P. Lerner ; David EidelbergEffects of levodopa on regional cerebral metabolism and blood flow.
000A19 (2013) David E. Vaillancourt [États-Unis] ; Daniel Schonfeld [États-Unis] ; Youngbin Kwak [États-Unis] ; Nicolaas I. Bohnen [États-Unis] ; Rachael Seidler [États-Unis]Dopamine overdose hypothesis: Evidence and clinical implications
000B23 (2013) Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia TrenkwalderAFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
000C63 (2012) Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl KieburtzPharmacologic approaches to the treatment of Huntington's disease.
001331 (2011) Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; P Nar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study
001350 (2011) Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
001401 (2011) Dimitrios Kapogiannis [États-Unis] ; Eric Mooshagian [États-Unis] ; Paul Campion [États-Unis] ; Jordan Grafman [États-Unis] ; Trelawny J. Zimmermann [États-Unis] ; Kelsey C. Ladt [États-Unis] ; Eric M. Wassermann [États-Unis]Reward processing abnormalities in Parkinson's disease
002227 (2009) Jane E. Alty [Australie] ; Benjamin G. Clissold [Australie] ; Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function
002419 (2009) Karim Farid [France] ; Igor Sibon [France] ; Dominique Guehl [France] ; Emmanuel Cuny [France] ; Pierre Burbaud [France] ; Michèle Allard [France]Brain dopaminergic modulation associated with executive function in Parkinson's disease
002442 (2009) Laura Marsh [États-Unis] ; Kevin Biglan [États-Unis] ; Melissa Gerstenhaber [États-Unis] ; James R. Williams [États-Unis]Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open‐label study
002473 (2009) Adrienne Curtis [Royaume-Uni] ; Ian Mitchell [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Hugh Rickards [Royaume-Uni]A pilot study using nabilone for symptomatic treatment in Huntington's disease
002589 (2008) Wendy Phillips [Royaume-Uni] ; Kathleen M. Shannon [États-Unis] ; Roger A. Barker [Royaume-Uni]The current clinical management of Huntington's disease
003B47 (2004) Giovanni Cossu [Italie] ; Maurizio Melis [Italie] ; Giannina Melis [Italie] ; Elisabetta Maccioni [Italie] ; Valeria Putzu [Italie] ; Olga Catte [Italie] ; Paolo Francesco Putzu [Italie]Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report
004100 (2003) James T. H. Yip [Hong Kong] ; Tatia M. C. Lee [Hong Kong] ; Shu-Leong Ho [Hong Kong] ; Kin-Lun Tsang [Hong Kong] ; Leonard S. W. Li [Hong Kong]Emotion recognition in patients with idiopathic Parkinson's disease
004494 (2002) Drugs to treat dementia and psychosis
004692 (2001) Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni]Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial
004B08 (2000) Jaime Kulisevsky [Espagne] ; Carmen García-Sánchez [Espagne] ; Marcelo L. Berthier [Espagne] ; Manel Barbanoj [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Armando Estévez-González [Espagne]Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two‐year follow‐up study of previously untreated patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Cognition Disorders (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Cognition Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cognition Disorders (drug therapy)
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024